Prescient said the acquisition will expand its lab capabilities and enhance its relationships with local, regional, and national health insurers.
NEW YORK (GenomeWeb) – PGXL Technologies today said that it has formed a partnership with NX PharmaGen under which the partners have created a research center focused on exosome analysis.
NEW YORK (GenomeWeb) – PGXL Laboratories has received licensure from California to provide its testing services in the state.
NEW YORK (GenomeWeb News) – Pharmacogenetic testing firm PGXL Laboratories announced on Thursday a long-term national distribution deal with Essential Molecular Testing for PGXL's drug sensitivity testing.
This article has been updated to include information about a competing product in the market.
PGXL, a Louisville, Ky.-based pharmacogenomics services provider, plans to introduce other AutoGenomics assays, such as its KRAS-BRAF test, in the future.
Starting next month, PGXL and Generation Health will provide pharmacogenetic testing and diagnostic services to patients through healthcare providers.
Australia will not be regulating gene editing of plants, animals, and human cell lines as long as no new genetic material is incorporated, reports Nature News.
The Washington Post reports that the US Department of Agriculture told its researchers to label peer-reviewed articles as "preliminary" work.
Researchers have sequenced the genomes of both the coast redwood and the giant sequoia, according to the San Francisco Chronicle.
In PNAS this week: study of epigenetic patterns in mammalian eggs, clonal expansion patterns in CD8+ T cells, and more.